DOW JONES22,115.33+478.55 2.21%
S&P 5002,607.59+66.12 2.60%
NASDAQ7,710.86+208.48 2.78%

Aptevo Therapeutics Offers Update On Ongoing APVO436 Trial: Says Is Advancing On Schedule, Dosing In Cohort 6 To Begin Shortly

Benzinga · 03/16/2020 13:07